ResearchMoz

Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019

GlobalData
Published Date » 2012-06-18
No. Of Pages » 65
   
 GlobalData, the industry analysis specialist, has released its new report, Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases,...
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6

2 Hepatitis A Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 8
2.2.1 Historical Vaccination Coverage (2006-2011) 9
2.2.2 Forecast Vaccination Coverage (2011-2019) 9
2.3 Prognosis 10
2.4 Etiology 10
2.5 Pathophysiology 12
2.6 Signs and Symptoms 13
2.7 Diagnosis 14
2.8 Treatment and Management Options 16
2.9 Referral Pathway 18
2.10 GlobalData Pipeline Report Guidance 20

3 Hepatitis A Preventive Vaccines - Market Characterization 21
3.1 Global Hepatitis A Preventive Vaccines Market Size (2006-2011) 21
3.2 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Global 22
3.3 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The US 23
3.4 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The US 24
3.5 Hepatitis A Preventive Vaccines Market Size (2006-2011) - France 25
3.6 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - France 26
3.7 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Germany 27
3.8 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Germany 28
3.9 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Italy 29
3.10 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Italy 30
3.11 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Spain 31
3.12 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Spain 32
3.13 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The UK 33
3.14 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The UK 34
3.15 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Japan 35
3.16 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Japan 36
3.17 Drivers and Barriers for the Hepatitis A Preventive Vaccines Market 37
3.17.1 Drivers for the Hepatitis A Preventive Vaccines Market 37
3.17.2 Barriers for the Hepatitis A Preventive Vaccines Market 37
3.18 Opportunity and Unmet Need Analysis 38
3.19 Key Takeaway 39

4 Hepatitis A Preventive Vaccines - Competitive Assessment 40
4.1 Overview 40
4.2 Strategic Competitor Assessment 40
4.3 Product Profiles for the Major Marketed class of Products in the Hepatitis A Market 41
4.3.1 Havrix 41
4.3.2 Vaqta 42
4.3.3 Twinrix 44
4.3.4 Ambirix 45
4.3.5 Avaxim 46
4.3.6 Epaxal 46
4.4 Key Takeaway 47

5 Hepatitis A Preventive Vaccines - Clinical Trials Mapping 48
5.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 48
5.2 Clinical Trials by Phase 49
5.3 Clinical Trials by Trial Status 50
5.4 Prominent Sponsors 51
5.5 Clinical Trials by Overall Sponsors 52
5.6 Top Companies Participating in Hepatitis A Preventive Vaccines Clinical Trials 53

6 Hepatitis A Preventive Vaccines - Strategic Assessment 54
6.1 Key Events Impacting the Future Market 54
6.2 Hepatitis A Preventive Vaccines: Implications for Future Market Competition 55

7 Hepatitis A Preventive Vaccines - Future Players 56
7.1 Introduction 56
7.2 Company Profiles 56
7.2.1 GlaxoSmithKline 56
7.2.2 Merck & Co 56
7.2.3 Crucell 57

8 KOL Insights 58

9 Hepatitis A Preventive Vaccines - Appendix 59

9.1 Market Definitions 59
9.2 Abbreviations 59
9.3 Bibliography 60
9.4 Methodology 61
9.4.1 Coverage 61
9.4.2 Secondary Research 61
9.4.3 Forecasting 62
9.4.4 Primary Research 64
9.4.5 Expert Panel Validation 65
9.5 Contact Us 65
9.6 Disclaimer 65

List of Tables


Table 1: Comparison between Hepatitis A, B and C 7
Table 2: HAV Endemicity by Region 8
Table 3: Vaccination Coverage (In Percentage) 9
Table 4: Vaccination Coverage (In Percentage) 9
Table 5: History and Physical Examination 14
Table 6: Laboratory and Other Studies for Hepatitis A 15
Table 7: Differential Diagnosis of hepatitis A 15
Table 8: Havrix Dosage and Schedule for Vaccination 16
Table 9: Vaqta Dosage and Schedule for Vaccination 16
Table 10: Twinrix Dosage and Schedule for Vaccination 16
Table 11: UK Guidelines For Hepatitis A Vaccination 17
Table 12: Japanese Hepatitis A Vaccine, Dosage and Schedule 17
Table 13: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 21
Table 14: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 22
Table 15 Hepatitis A Preventive Vaccines Market, The US, Revenue ($m), 2006-2011 23
Table 16: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 24
Table 17: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 25
Table 18: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 26
Table 19: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 27
Table 20: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 28
Table 21: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 29
Table 22: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 30
Table 23: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 31
Table 24: Hepatitis A Preventive Vaccines, Spain, Forecast ($m), 2011-2019 32
Table 25: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 33
Table 26: Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 34
Table 27: Hepatitis A Market, Japan, Revenue ($m), 2006-2011 35
Table 28: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 36
Table 29: Hepatitis A Preventive Vaccines - Clinical Trials by Region/ Country, 2012 48
Table 30: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 49
Table 31: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 50
Table 32: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 51
Table 33: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 52
Table 34: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 53

List of Figures


Figure 1: Prevalence of Hepatitis A Virus by Region 8
Figure 2: Incidence of Hepatitis A, 1980-2009 10
Figure 3: Pathophysiology of Hepatitis A 12
Figure 4 : Symptoms of Hepatitis A infection 13
Figure 5: Referral Pathway for HAV Vaccination 18
Figure 6: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 19
Figure 7: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 21
Figure 8: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 22
Figure 9 Hepatitis A Preventive Vaccines, The US, Revenue ($m), 2006-2011 23
Figure 10: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 24
Figure 11: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 25
Figure 12: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 26
Figure 13: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 27
Figure 14: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 28
Figure 15: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 29
Figure 16: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 30
Figure 17: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 31
Figure 18: Hepatitis A Preventive Vaccines Market, Spain, Forecast ($m), 2011-2019 32
Figure 19: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 33
Figure 20 : Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 34
Figure 21 : Hepatitis A Preventive Vaccines Market, Japan, Revenue ($m), 2006-2011 35
Figure 22: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 36
Figure 23: Opportunity and Unmet Need in the Hepatitis A Preventive Vaccines Market, 2012 38
Figure 24: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 39
Figure 25: Hepatitis A Preventive Vaccines - Strategic Competitor Assessment, 2012 41
Figure 26: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 47
Figure 27: Hepatitis A Preventive Vaccines - Clinical Trials by Country, 2012 48
Figure 28: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 49
Figure 29: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 50
Figure 30: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 51
Figure 31: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 52
Figure 32: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 53
Figure 33: Hepatitis A Preventive Vaccines Market - Drivers and Restraints 2012 54
Figure 34: Implications for Future Market Competition in Hepatitis A Preventive Vaccines Market, 2012 55
Figure 35: Hepatitis A Preventive Vaccines - Marketed Products by Company, 2012 56
Figure 36: KOL Insights, Hepatitis A Preventive Vaccines, Major Market 58
Figure 37: GlobalData Market Size Estimation 62
Figure 38 : GlobalData Market Forecasting Model 64

Upcoming Reports:

3D/4D Technology Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
The 3D technology has gained quite a momentum in past few years and is being widely used in entertainment industry. Earlier 3D technology was expensive and difficult to use and was only confined to entertainment and gaming industry but over a period of time 3D technology is being used in wide range of applications. Introduction of 3D TVs and smartphones have become next big trend. Some of the factors contributing to the growth of 3D and 4D technology market are the growing gaming and entertainment industry. The generation of 3D movies is boosting the revenue of 3D technology...
Bone and Joints Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Bone and joints ingredients are those elements which are taken as supplement in order to maintain healthy bones and joints. These value added ingredients help in increasing the strength and flexibility of the bones and joints in the body. There are various bone and joint ingredients including calcium, soy isoflavone and collagen. For instance, calcium is the most popular bone ingredient. It is an established ingredient with a mature market. Soy isoflavone is another key bone health ingredient maintaining bone mineral density (BMD) and preventing bone loss. The most important...
Powder Metallurgy (PM) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Powder Metallurgy (PM) is a method of mixing fine powdered metals or alloy materials and compressing them into a desired form or shape and then heating it in a controlled environment to bond the compressed material. The process generally involves four steps, viz., powder manufacturing, blending, compacting and sintering. The highly precise forging capability of PM helps build components with net shape, dimensional precision and elaborate features. The key driver for PM is their large application base in the automotive industry and majority of applications worldwide for this...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...